Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zonisamide SR Plus Bupropion SR in Obesity
NCT00709371Phase 2Completed
- Sponsor
- Orexigen Therapeutics
- Start
- Jul 2008
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zonisamide, bupropion in obesity, sponsored by Orexigen Therapeutics. Started Jul 2008; status: completed.
02
Drugs
zonisamidebupropion
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00709371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00709371.